InvestorWaves

Stories

View all stories
Ranked dumbbell chart showing launch price versus 2026 price for standard ad-free streaming plans. Disney+ rises from $6.99 to $21.49, Apple TV+ from $4.99 to $14.99, Netflix from $7.99 to $19.99, Peacock from $9.99 to $19.99, Hulu from $11.99 to $21.49, Paramount+ from $9.99 to $13.99, and HBO Max from $14.99 to $18.49.
Streaming's Ad-Free Price Climb
Consumer

Streaming's Ad-Free Price Climb

Bar chart showing the combined index weight of the two largest S&P 500 constituents from 1980 through 2026. The series dips near 5% in the 1990s, rises sharply after 2019, and reaches 15.7% in 2026 for Nvidia and Apple.
Two Stocks Are 16% Of The S&P 500
Market Concentration

Two Stocks Are 16% Of The S&P 500

Line chart titled From 1% To 5%, showing the 30-year U.S. Treasury yield from 2020 to 2026. The chart labels a 0.99% low on March 9, 2020, and a 5.40% latest official close near 2026, with a note that the yield is at its highest level since 2004.
From 1% to 5%
Rates

From 1% to 5%

Ranked horizontal bar chart titled Robots Need Muscles, showing the largest index weights in the Defiance Robotics Actuators ETF as of September 23, 2026. Fanuc is 7.95%, SMC is 7.76%, Nidec is 7.66%, RBC Bearings is 6.81%, SKF is 6.08%, Regal Rexnord is 5.36%, Timken is 4.94%, Moog is 4.59%, Shenzhen Inovance is 4.44%, Yaskawa is 4.35%, Airtac is 4.32%, and THK is 3.96%. A note says Defiance cites McKinsey estimating actuators at 40%-60% of a humanoid robot's bill of materials.
Robots Need Muscles
AI Infrastructure

Robots Need Muscles

Chartr-style horizontal bar chart comparing Meta Muse and ChatGPT early mobile launch metrics. Muse reached 1.8 million U.S. and Canada iOS downloads in its first 12 days versus 1.3 million for ChatGPT. Muse reached 642,000 U.S. mobile daily active users by day 12 versus 231,000 for ChatGPT. A callout says Muse reached roughly 450,000 U.S. DAUs by day 10, while ChatGPT took 49 days.
Muse Beat ChatGPT's Mobile Launch
AI Apps

Muse Beat ChatGPT's Mobile Launch

Chartr-style line chart showing the U.S. 30-year fixed mortgage rate over the last 10 years. Rates were around 3.48% in 2016, fell to a 2.65% low in early 2021, rose to a 7.79% high in 2023, and are shown back above 7% at 7.17% in September 2026. A dashed horizontal line marks the 7% level.
Mortgage Rates Are Back Above 7%
Housing

Mortgage Rates Are Back Above 7%

Line chart showing WTI crude futures rising from around $80 in mid-July 2026 to a mid-September peak near $106 before falling to about $90 on Sept. 22 amid reports of a possible Strait of Hormuz reopening path.
Oil's Hormuz Premium Is Leaking Out
macro

Oil's Hormuz Premium Is Leaking Out

Horizontal bar chart comparing FY2025 revenue, showing Kirkland Signature at $90 billion above Procter & Gamble, Coca-Cola, Nike, Starbucks, McDonald's, and lululemon.
Kirkland Is a $90B Brand
stocks

Kirkland Is a $90B Brand

Stock Ideas

View all ideas
TNET

Trinet Group, Inc.

Trinet combines enterprise-focused HR services with re-accelerating GAAP quarterly EPS growth, heavy institutional ownership, and an established Stage 2 uptrend within Enterprise & Vertical Software.

Enterprise & Vertical Software
MANH

Manhattan Associates Inc

Manhattan Associates pairs accelerating revenue growth with an established Stage 2 technical uptrend, making it a timely leader in enterprise logistics and vertical software solutions.

Enterprise & Vertical Software
MEDP

Medpace Holdings, Inc.

Medpace, a clinical research services leader, combines consistent double-digit revenue growth and high institutional ownership, making it a timely leader in Life Science Tools & CDMO.

Life Science Tools & CDMO
ARGX

Argenx Se

Argenx's validated Stage 1→2 breakout, reclaimed 200-day trend, and substantial institutional ownership position it as a timely technical leader within Biotech Therapeutics with improving relative strength.

Biotech Therapeutics
BIO

Bio-Rad Laboratories, Inc.

Bio‑Rad is a leading life‑science tools company with steady quarterly revenue, heavy institutional ownership, and recent strong relative performance versus the S&P, positioning it as a timely theme leader.

Life Science Tools & CDMO
BRKR

Bruker Corp

Bruker is positioned as a life-science tools leader with accelerating revenue, a confirmed uptrend, and heavy institutional sponsorship that has driven strong relative performance versus the S&P.

Life Science Tools & CDMO

Market insights

View all insights
PAYXhigh signal

Enterprise HCM bookings remain strong

Double-digit enterprise bookings and high-single-digit growth among larger customers signal durable demand for workforce-management platforms, including through broker channels.

enterprise HCMbookingsbroker channelworkforce software
Read insight
PAYXhigh signal

Workforce platforms are moving upmarket

Positive enterprise trends and further-upmarket PEO activity indicate that employers are increasingly seeking broader, integrated workforce solutions rather than standalone payroll tools.

upmarket demandPEOenterprise softwareHCM
Read insight
PAYXhigh signal

Embedded AI is becoming the enterprise standard

Management’s emphasis on AI embedded in systems of record suggests enterprise buyers may favor workflow-integrated automation over separate generative-AI interfaces.

embedded AIsystems of recordworkflow automationenterprise technology
Read insight

Market insights, made visual.

Get data-driven insights into stocks and investing themes in a free newsletter that takes 5 minutes to read.

Market insights, made visual.

Get data-driven insights into stocks and investing themes in a free newsletter that takes 5 minutes to read.

Join free. Unsubscribe anytime.